Canada Life’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$109M Sell
371,297
-10,897
-3% -$3.58M 0.2% 102
2025
Q4
$134M Buy
382,194
+90,209
+31% +$30.5M 0.23% 81
2025
Q3
$93.3M Buy
291,985
+3,440
+1% +$1.07M 0.13% 132
2025
Q2
$112M Buy
288,545
+12,520
+5% +$5.04M 0.18% 111
2025
Q1
$120M Sell
276,025
-8,355
-3% -$3.35M 0.21% 94
2024
Q4
$105M Sell
284,380
-63,899
-18% -$26.7M 0.18% 99
2024
Q3
$181M Buy
348,279
+26,258
+8% +$14M 0.32% 55
2024
Q2
$175M Buy
322,021
+22,450
+7% +$11.9M 0.33% 51
2024
Q1
$155M Sell
299,571
-13,233
-4% -$6.58M 0.31% 59
2023
Q4
$147M Buy
312,804
+12,091
+4% +$5.59M 0.32% 60
2023
Q3
$131M Sell
300,713
-7,113
-2% -$3.23M 0.31% 65
2023
Q2
$137M Sell
307,826
-6,744
-2% -$3.11M 0.33% 58
2023
Q1
$145M Buy
314,570
+4,265
+1% +$2.03M 0.36% 54
2022
Q4
$160M Buy
310,305
+35,958
+13% +$18.3M 0.42% 46
2022
Q3
$125M Sell
274,347
-5,235
-2% -$2.5M 0.35% 52
2022
Q2
$135M Sell
279,582
-1,006
-0.4% -$498K 0.36% 55
2022
Q1
$145M Sell
280,588
-9,921
-3% -$4.53M 0.3% 65
2021
Q4
$134M Sell
290,509
-15,029
-5% -$6.32M 0.28% 67
2021
Q3
$115M Buy
305,538
+11,909
+4% +$4.53M 0.27% 70
2021
Q2
$112M Sell
293,629
-37,580
-11% -$14.4M 0.26% 75
2021
Q1
$118M Sell
331,209
-70,395
-18% -$22.6M 0.29% 68
2020
Q4
$129M Buy
401,604
+10,570
+3% +$3.24M 0.24% 93
2020
Q3
$105M Buy
391,034
+32,284
+9% +$8.69M 0.23% 102
2020
Q2
$94M Buy
358,750
+94,698
+36% +$25.3M 0.22% 109
2020
Q1
$60.3M Buy
264,052
+172
+0.1% +$46.9K 0.16% 141
2019
Q4
$79.1M Sell
263,880
-93,066
-26% -$25.6M 0.17% 131
2019
Q3
$85.8M Sell
356,946
-5,199
-1% -$1.42M 0.2% 118
2019
Q2
$102M Buy
+362,145
New +$98.9M 0.23% 103
2019
Q1
Sell
-331,208
Closed -$82.7M 2677
2018
Q4
$82.7M Buy
331,208
+4,506
+1% +$1.24M 0.24% 101
2018
Q3
$89.6M Sell
326,702
-18,186
-5% -$4.72M 0.21% 110
2018
Q2
$82.1M Buy
344,888
+19,334
+6% +$4.48M 0.19% 121
2018
Q1
$71.6M Buy
325,554
+2,439
+0.8% +$573K 0.17% 131
2017
Q4
$72.6M Sell
323,115
-135,799
-30% -$28.9M 0.17% 131
2017
Q3
$87M Buy
458,914
+78,262
+21% +$14.9M 0.22% 103
2017
Q2
$71.5M Buy
380,652
+12,776
+3% +$2.3M 0.19% 118
2017
Q1
$60.8M Sell
367,876
-2,963
-0.8% -$471K 0.16% 137
2016
Q4
$53.5M Sell
370,839
-5,736
-2% -$768K 0.15% 148
2016
Q3
$47.2M Buy
376,575
+11,592
+3% +$1.5M 0.14% 158
2016
Q2
$47.8M Buy
364,983
+55,898
+18% +$7.65M 0.14% 158
2016
Q1
$42.9M Buy
309,085
+85,378
+38% +$11.4M 0.16% 152
2015
Q4
$31.2M Buy
223,707
+3,452
+2% +$476K 0.12% 192
2015
Q3
$30.9M Sell
220,255
-8,683
-4% -$1.3M 0.12% 179
2015
Q2
$37.5M Buy
228,938
+18,745
+9% +$2.99M 0.13% 183
2015
Q1
$32.4M Sell
210,193
-49,385
-19% -$7.03M 0.11% 211
2014
Q4
$32.6M Buy
259,578
+18,947
+8% +$2.34M 0.11% 208
2014
Q3
$28.9M Buy
240,631
+5,128
+2% +$588K 0.1% 222
2014
Q2
$25.3M Buy
235,503
+27,717
+13% +$2.86M 0.08% 252
2014
Q1
$20.6M Buy
207,786
+9,437
+5% +$854K 0.07% 282
2013
Q4
$18.4M Buy
198,349
+35,132
+22% +$3.12M 0.07% 298
2013
Q3
$13.6M Buy
163,217
+154,496
+1,772% +$13.2M 0.05% 323
2013
Q2
$714K Buy
+8,721
New +$653K ﹤0.01% 503

Other funds holding ELV

Canada Life's ELV Position: Q1 2026 in Review

Canada Life reduced its Elevance Health (ELV) stake by 2.9% in Q1 2026, selling an estimated $3.58M and leaving 371,297 shares worth $109M. The position accounts for 0.2% of the portfolio, ranked #102.

Canada Life first reported a position in ELV in Q2 2013 and has held it in 51 quarters since. The position peaked at $181M in Q3 2024. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Canada Life held 371,297 shares of Elevance Health worth $109M as of Q1 2026.
  • Canada Life sold 10,897 Elevance Health shares in Q1 2026, an estimated $3.58M.
  • Elevance Health made up 0.2% of Canada Life's portfolio in Q1 2026, its #102 holding.
  • Canada Life first reported a position in Elevance Health in Q2 2013 and has held it in 51 quarters since.
  • Canada Life's Elevance Health position peaked at $181M in Q3 2024.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.